Two experimental osteoporosis drugs showed promise in clinical trials and increased bone mineral density in postmenopausal women with osteoporosis, according to researchers.
The jury is still out on a new, controversial osteoporosis drug Pfizer hopes to market. Fablyn may have some additional risk for cancer and was rejected by the FDA three years ago. Approval could mean $500 million a year for Pfizer.
New published research out of Children's Hospital, Boston, finds that 28 percent of young children are facing a risk of vitamin D deficiency while 12 percent are already deficient. Breast-fed infants are often deficient and supplementation is suggested.
Exposure to ten minutes of sunshine a day without sunscreen may help provide valuable vitamin D that is increasingly being shown to be important in the fight against breast cancer.
In yet another study, Fosamax is linked to the risk of developing atrial fibrillation, an irregular heart beat. But researchers conclude that the benefits of drugs in this class that fight the ravages of osteoporosis, outweigh the risks.
If you are overwhelmed by your January resolutions to hit the gym - relax. As little as ten minutes a day can deliver vitality, uplifted mood and strength to postmenopausal women according to an ongoing American Heart Association study.
Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery. We are committed to serving the public with honesty and integrity in these efforts.
On the Road
Major Medical
Protecting Your Family
In the Workplace
Zhu Zhu Pet Mr. Squiggles Under The Microscope For Hazards
Second Recall For Tainted Beef In Arizona, New Mexico
One Quarter Teens Get Merck HPV Vaccine
Crash That Led To Toyota Recall ‘Inconclusive’
Genetically Modified Rice Trial Cost Bayer $2 Million
Toyota Corolla, Matrix Sudden Stalls Focus Of NHTSA Probe
Consumer Reports: Toyota Tops Sudden Acceleration In 2008 Models